EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Integra Lifesciences Holdings's Enterprise Value is $3,682 Mil.
Integra Lifesciences Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $132 Mil. Therefore, Integra Lifesciences Holdings's EV-to-EBIT for today is 27.80.
The historical rank and industry rank for Integra Lifesciences Holdings's EV-to-EBIT or its related term are showing as below:
IART'
s EV-to-EBIT Range Over the Past 10 Years
Min: -153.11 Med: 36.04 Max: 134.29
Current: 27.8
During the past 13 years, the highest EV-to-EBIT of Integra Lifesciences Holdings was 134.29. The lowest was -153.11. And the median was 36.04.
IART's EV-to-EBIT is ranked worse than 66.88% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 19.86
vs IART: 27.80
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Integra Lifesciences Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $4,777 Mil.
Integra Lifesciences Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $132 Mil. Integra Lifesciences Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.77%.
Integra Lifesciences Holdings EV-to-EBIT Historical Data
The historical data trend for Integra Lifesciences Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Integra Lifesciences Holdings's EV-to-EBIT
For the Medical Devices subindustry, Integra Lifesciences Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integra Lifesciences Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Integra Lifesciences Holdings's EV-to-EBIT falls into.
Integra Lifesciences Holdings's current Enterprise Value is $3,682 Mil.
Integra Lifesciences Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $132 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Integra Lifesciences Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was $4,777 Mil.
Integra Lifesciences Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $132 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integra Lifesciences Holdings EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Integra Lifesciences Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Integra Lifesciences Holdings (Integra Lifesciences Holdings) Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IART has been successfully added to your 